MAR 17, 2020 1:25 PM PDT

Cancer and the risk of AFib

Research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC) suggests that people who have had cancer have a higher risk of developing atrial fibrillation. Atrial fibrillation, known more colloquially as AFib, is the most common heart rhythm disorder.

The hearts of people who have AFib don’t keep rhythm correctly, which can result in people experiencing palpitations, fatigue and dizzy spells. If people do not receive treatment, AFib can ultimately cause blood clots, putting individuals at five times the risk for stroke and heart failure.

The research signals that people who have had a prostate cancer diagnosis are at the highest risk of developing AFib, followed by people who have had colon, lung, and breast cancers.

"When we looked at everyone with some form of AFib, those with certain types of cancer were more likely to have heart rhythm abnormalities, and this trend persisted even after accounting for other cardiovascular risk factors and disease," said Muhammad Khan, MD, a resident at St. Mary Medical Center in Langhorne, Pennsylvania, and the study's lead author. "We found 2.3-fold increased odds of having AFib with all cancers studied. There was a greater than 50% increased risk of AFib in prostate, colon, and lung cancer patients. Of these three, those with prostate cancer had the highest risk of AFib."

The researchers were interested in what aspects of specific cancers made people more susceptible to AFib when compared to other cancers. They analyzed data from 143 million adults in the US to determine the rate of coexistence between AFib and certain cancers.

"For example, these cancers may be associated with higher mortality due to circulating pro-coagulants and greater systemic inflammation, but this relationship has yet to be studied," he said. "Based on our findings, certain patients should be considered at higher risk of AFib and may benefit from cardiac evaluation and appropriate treatments, whether it be with medication or ablative techniques, to help improve the survival rates in the long-term."

Photo: Pixabay

While the researchers say they do not understand exactly why prostate cancer showed a particular link to a higher risk for AFib, Khan hypothesizes that it might have to do with age. "The mean age of prostate cancer diagnosis and AFib is around the same--generally 66 years--so there may be a correlation between the two due to the similar age of onset. Given the older age of onset, these patients tend to have more comorbidities that may contribute to them developing AFib," Khan said.

Khan and his colleagues plan to continue their research in order to improve general understanding between the link that certain cancers have with AFib. They hope their findings will improve AFib treatment in the future and even prevent new cases.

Sources: Eureka Alert, ACC

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
AUG 21, 2020
Cancer
Firefighters risk greater carcinogenic exposure than previously thought
AUG 21, 2020
Firefighters risk greater carcinogenic exposure than previously thought
New research published in the journal Environment International suggests that firefighters may be more exposed to c ...
SEP 02, 2020
Cancer
New contrast dyes detect cancer using tatoo ink
SEP 02, 2020
New contrast dyes detect cancer using tatoo ink
Researchers have developed new cancer detection agents in the form of contrast dyes from tattoo ink. The results of thes ...
SEP 17, 2020
Cardiology
Can Grape Polyphenol Extracts prevent Cardiotoxicity?
SEP 17, 2020
Can Grape Polyphenol Extracts prevent Cardiotoxicity?
One of the biggest issues with chemotherapy treatments is their inherent toxicities. Most chemotherapy drugs are toxic t ...
SEP 28, 2020
Cancer
A New Transcriptomics Program in the Works Glioma Diagnosis
SEP 28, 2020
A New Transcriptomics Program in the Works Glioma Diagnosis
The future of medicine is “personalized healthcare.” However, testing remains a critical hurdle researcher&r ...
OCT 05, 2020
Health & Medicine
Cannabis Chemotherapy Trial Shows Encouraging Phase II Results
OCT 05, 2020
Cannabis Chemotherapy Trial Shows Encouraging Phase II Results
Even with the best anti-nausea medications one in three patients receiving chemotherapy experiences vomiting, and about ...
OCT 20, 2020
Clinical & Molecular DX
Non-coding RNA As A Barometer For Liver Health
OCT 20, 2020
Non-coding RNA As A Barometer For Liver Health
October is liver cancer awareness month — a month dedicated to educating people about the risk factors and prevent ...
Loading Comments...